Perspectives on Biomarker and Surrogate Endpoint Evaluation : Discussion Forum Summary.

Afficher d'autres versions (1)
Détails bibliographiques
Cote:Libro Electrónico
Auteur principal: Mack, Alison
Autres auteurs: Balogh, Erin
Format: Électronique eBook
Langue:Inglés
Publié: Washington : National Academies Press, 2009.
Sujets:
Biochemical markers > United States > Evaluation.
Drugs > Testing.
Clinical trials.
Chronic diseases.
Medical personnel.
Diseases.
Evidence-based medicine.
Health Occupations
Disease Attributes
Pathologic Processes
Disciplines and Occupations
Pathological Conditions, Signs and Symptoms
Disease
Evidence-Based Practice
Chronic Disease
Clinical Trials as Topic
Health Personnel
Health Workforce.
Evidence-Based Medicine
Marqueurs biologiques > États-Unis > Évaluation.
Médicaments > Essais cliniques.
Études cliniques.
Maladies chroniques.
Personnel médical.
Maladies.
Médecine factuelle.
illness.
disease.
Medical personnel
Evidence-based medicine
Diseases
Biochemical markers > Evaluation
Chronic diseases
Clinical trials
Drugs > Testing
United States
Accès en ligne:Texto completo
Table des matières:
  • ""FrontMatter""; ""Reviewers""; ""Contents""; ""1 Introduction""; ""2 Committee Findings and Recommendations""; ""3 FDA Perspectives""; ""4 National Institutes of Health Perspectives""; ""5 Industry Perspectives""; ""6 Public Health, Consumer, and Consulting Organization Perspectives""; ""7 Presentation by Thomas Fleming: Biomarkers and Surrogate Endpoints in Chronic Disease""; ""8 Key Themes, Challenges, and Opportunities""; ""9 Importance of the Biomarker Discussion Forum""; ""References""; ""Acronyms""; ""Glossary""; ""Appendix A: Discussion Forum Agenda""

Documents similaires